share_log

HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $5

Benzinga ·  Jan 8 08:17

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and raises the price target from $4 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment